Low PCSK9 levels are correlated with mortality in patients with end-stage liver disease.

Low PCSK9 levels are correlated with mortality in patients with end-stage liver disease.

Proprotein convertase subtilisin/kexin type 9 (PCSK9) plays a key role in the cholesterol metabolism and is synthesized by the liver. It interacts with the LDL-receptor to promote its degradation. The model of end-stage liver disease (MELD) score is a well-established tool to estimate the risk of mo...

Full description

Bibliographic Details
Main Authors: Valentin Schlegel, Theresa Treuner-Kaueroff, Daniel Seehofer, Thomas Berg, Susen Becker, Uta Ceglarek, Joachim Thiery, Thorsten Kaiser
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5519179?pdf=render

Internet

http://europepmc.org/articles/PMC5519179?pdf=render

Similar Items